1Zalel Y,Seidman DS,Oren M,et al.Sonographic and clinical characteristics of struma ovarii.J Ultrasound Med,2000,19:857-861.
2Dardik RB,Dardik M,Westra W,et al.Malignant struma ovarii:two case reports and a review of the literature.Gynecol Oncol,1999,73:447-451.
3Ribeiro-Silva A,Bezerra AM,Serafini LN,et al.Malignant struma ovarii:an autopsy report of a clinically unsuspected tumor.Gynecol Oncol,2002,87:213-215.
4Teale E,Gouldesbrough DR,Peacey SR.Graves,disease and coexisting struma ovarii:struma expression of thyrotrop in receptors and the presence of thyrotrop in receptors stimulating antibodies.Thyroid,2006,16:791-793.
5Outwater EK,Siegelman ES,Hunt JL,et al.Ovarian teratomas:tumor types and imaging characteristics.Radiographics,2001,21:475-490.
7Savelli L,Testa AC,Timmerrnan D,et al.Analysis of gynecological disease (4):clinical and Doppler features of struma ovarii.Ultrasound Obstet Gynecol,2008,32:210-219.
9Buttin BM,Cohn DE,Herzog TJ.Meigs' syndrome with an ekevated CA125 from benign Brenner tumors:in process citation.Obstet Gynecol,2001,98:980-982.
10Takeuchi K,Murata K,Fujita I,et al."Malignant struma ovarii" with peritoneal metastasis:report of two cases.Eur J Gynaecol Oncol,2000,21:260-261.
二级参考文献9
1Roth LM, Talerman A. Recent advances in pathology and classification of ovarian germ cell tumors [ J ]. Int J Gynecol Pathol,2006,25 : 305-320
2DeSimone CP, Lele SM, Modesitt SC. Malignant struma ovarii:a case report and analysis of cases reported in the literature with focus on survival and ^131Ⅰ therapy [ J ]. Gynecol Oncol,2003,89 : 543 -548
3Tavassoli FA, Devilee P. World health orgnization classification of tumours. Pathology and Genetics, tumors of the breast and female genital organs [ M ]. Lyon: IARC Press, 2003 : 163-175
5Loizzi V, Cormio G, Resta L, et al. Pseudo-Meigs syndrome and elevated CA125 associated with struma ovarii[J ]. Gynecol Oncol,2005,97:282-284
6Teale E, Gouldesbrough DR, Peacey SR. Graves′ disease and coexisting struma ovarii: struma expression of thyrotropin receptors and the presence of thyretropin receptor stimulating antibodies [ J ]. Thyroid,2006,16:791-793
7Kabukcuoglu F, Baksu A, Yilmaz B, et al. Malignant struma ovarii [ J ]. Pathol Oncol Res,2002,8 : 145-147
8Bolat F, Erkanli S, Kayaselcuk F, et al. Malignant stmma ovarii : a case report [ J ]. Pathol Res Pract, 2005,201 : 409-412
3Brown J, Shvartsman HS, Deavers MTT,at al. The activity of taxanes compared with bleomycin, etoposide, and eisplatin in the treatment of sex cord-stromal ovarian tumors [ J ]. Gynecol Oncol, 2005,97(2) :489-496.
4Brewer M, Gershenson DM, Herzog CE, et al. Outcome and reproductive function after chemotherapy for ovarian dysgerminoma [J].J Clin Oncol, 1999, 17(9) : 2670-2675.
5Kondagunta GV, Bacik J, Donadio A, at al. Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors [J]. J Clin Oncol,2005,23 (27) :6549-6555.
6Einhorn LH, Williams SD, Chamness A, at al. High-dose chemotherapy and stern-cell rescue for metastatic germ-cell tumors [ J ]. N Engl J Med,2007,357 ( 4 ) : 340 -348.
7Schumer ST, Cannistra SA. Granulosa cell tumor of the ovary [J]. J Clin Oncol, 2003,21(6):1180-1189.
8Schneider DT, Calaminus G, Wessalowski R, at al. Ovarian sex cord-stromal tumors in children and adolescents [ J ]. J Clin Oncol, 2003, 21 (12):2357-2363.
9Gershenson DM, Copeland LJ, Kavanagh JJ, et al. Treatment of metastatic stromal tumors of the ovary with cisplatin, doxorubicin, and cyclophosphamide [J]. Obstet Gynecol, 1997, 70 (5) :765- 769.
10Pautier P, Gutierrez-Bonnaire M, Rey A, at al. Combination of bleomycin, etoposide, and cisplatin for the treatment of advanced ovarian granulosa cell tumors[J]. Int J Gynecol Cancer, 2008,18 ( 3 ) :446-452.
